MYSM1-mediated epigenetic modification dysregulation leads to immunosuppression and secondary infections in sepsis
PLOS Pathogens · 2026
DOI: 10.1371/journal.ppat.1013935 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, 2026. Verfasst von Jiali Xiong und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency, Renmin Hospital of Wuhan University, Wuhan, Hubei, PR China. Hauptthemen laut MEDLINE: Sepsis, Epigenesis, Genetic, Immune Tolerance, Histone Acetyltransferases. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hubei Provincial key Research and Development Program, National Key R&D Program Special Project on Technology Response to Active Health and Population Aging, National Key R&D Program Special Project on Diagnostic and Therapeutic Equipment and Biomedical Technology.
Themen: Sepsis
Abstract (Originalsprache)
Sepsis is a life-threatening condition characterized by a dysregulated immune response to infection, often leading to organ dysfunction and even death. During the recovery phase of sepsis, patients frequently exhibit impaired antimicrobial function of immune cells, which exacerbates the state of immunosuppression and increases the risk of secondary infections. However, therapeutic strategies targeting sepsis-induced immunosuppression have yet to achieve breakthrough progress, with the core challenge lying in the significant gaps in understanding the molecular mechanisms underlying immunosuppression. In this study, we integrated clinical samples, mouse models, and molecular mechanisms to reveal that the reduction in macrophage function and epigenetic dysregulation, particularly histone ubiquitination, are central drivers of sepsis-induced immunosuppression. Further investigation demonstrated that MYSM1, a deubiquitinase, plays a pivotal role in regulating this ubiquitination process. Targeted deletion of the N-terminal domain of MYSM1 markedly enhances the inflammatory response during the early phase of secondary infection in sepsis, facilitating bacterial clearance and significantly mitigating tissue damage in the late phase of secondary infection, thereby improving the survival outcomes in mice. Overall, our study elucidates the role of MYSM1-mediated dysregulation of epigenetic modifications in the immune response during the late phase of sepsis, providing a novel therapeutic approach for addressing sepsis-related immune dysfunction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Emergency, Renmin Hospital of Wuhan University, Wuhan, Hubei, PR China.
- Department of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, Hubei, PR China.
- Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, Beijing, PR China.
- Department of Oncology, Renmin Hospital of Wuhan University, Wuhan, Hubei, PR China.
- Department of Clinical Laboratory, Institute of Translational Medicine, Renmin Hospital of Wuhan University, Wuhan, Hubei, PR China.
- Postgraduate Training Base at Shanghai Gongli Hospital, Ningxia Medical University, Shanghai, PR China.
ORCID-Profile: Jingjun Lv
Förderung
- Hubei Provincial key Research and Development Program
- National Key R&D Program Special Project on Technology Response to Active Health and Population Aging
- National Key R&D Program Special Project on Diagnostic and Therapeutic Equipment and Biomedical Technology
- National Natural Science Foundation of China
Zitieren
APA
Xiong, J., Cheng, X., Xiong, X., Zhang, H., An, Q., Li, Z., Fan, H., Li, G., Li, W., Tian, M., & Lv, J. (2026). MYSM1-mediated epigenetic modification dysregulation leads to immunosuppression and secondary infections in sepsis. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1013935
Vancouver
Xiong J, Cheng X, Xiong X, Zhang H, An Q, Li Z, et al. MYSM1-mediated epigenetic modification dysregulation leads to immunosuppression and secondary infections in sepsis. PLOS Pathogens. 2026. doi:10.1371/journal.ppat.1013935
BibTeX
@article{Xiong2026,
author = {Xiong, Jiali and Cheng, Xin and Xiong, Xiaoxing and Zhang, Heyang and An, Qi and Li, Zhiqiang and Fan, Hong and Li, Guangli and Li, Wei and Tian, Mingfu and Lv, Jingjun},
title = {MYSM1-mediated epigenetic modification dysregulation leads to immunosuppression and secondary infections in sepsis},
journal = {PLOS Pathogens},
year = {2026},
doi = {10.1371/journal.ppat.1013935}
}
EUVIMED